Business Categories Reports Podcasts Events Awards Webinars
Contact My Account About

Nature Made Vitamins Owner Buys Bonafide Health in $425 Million Deal

Published November 30, 2023
Published November 30, 2023
Bonafide

Otsuka Holdings–backed Pharmavite, the maker of Nature Made vitamins, will acquire women’s health company Bonafide Health in an all-cash $425 million deal.

WHO: Bonafide Health was founded in 2017 to create a new class of over-the-counter, scientifically formulated, nature-inspired women’s health products with clinical evidence and doctor support. Powered by intellectual property and backed by clinical trials and endorsements from healthcare professionals, Bonafide Health’s six core products under the names Revaree, Relizen, Ristela, Clairvee, Serenol, and The Silvessa System focus on delivering long-term, sustainable support for needs that compound with age, including hot flashes, vaginal dryness, vaginal microbiome, sexual satisfaction, and more.

Pharmavite is a pioneer in the health and wellness industry, earning the trust of consumers, healthcare professionals, and retailers by developing innovative vitamin and supplement solutions backed by science that adhere to strict manufacturing practices. Through its Nature Made, Bonafide, Nature Made Wellblends, Equelle, MegaFood, Nurish by Nature Made and Uqora brands, the brand is dedicated to helping people live healthier, more vital lives. Based in California, Pharmavite is a subsidiary of Otsuka Pharmaceutical.

WHY: This is the continuation of Pharmavite’s ongoing commitment to bring the gift of health to life for all—including historically underserved categories. Through the acquisition of Bonafide Health, Pharmavite is expanding and complementing its existing women’s health business to continue to grow the category, which has been a priority. 

IN THEIR OWN WORDS: “This acquisition positions us as the nation’s leading women’s health nutraceutical company, signaling a new era of innovation and science-based solutions in this under-served space,” said Pharmavite Chief Executive Officer Jeff Boutelle.

He added, "Including Nature Made’s prenatal vitamins, Pharmavite’s offerings now cover a range of products in a growing multibillion-dollar market. Future mergers and acquisitions are definitely in our mindset.”

“Our steadfast commitment to science and innovation has allowed us to build something special at Bonafide Health and we’ve been looking for the right partner to grow the business and reach more women that need support. Pharmavite is that partner,” said Michael Satow, co-founder and CEO of Bonafide Health. “Pharmavite deeply understands the importance of the model we’ve built, from the rigorous scientific data that underpins our products, to the power of the work we do with the doctors and other health care providers who are having conversations with women across the country looking for better solutions.”

He continued, “We felt for a long time that it’s an area of tremendous unmet need, there’s a demand there. There are more than 30 different symptoms of menopause. Our mission is to help women with hopefully all of them.”

DETAILS:

  • Bonafide Health will continue to operate out of its current headquarters in Harrison, New York, and there will be no workforce implications post-transaction. 
  • Pharmavite was advised by Houlihan Lokey. William Hood & Company served as lead financial advisor and Evolution Life Science Partners served as co-advisor to Bonafide Health in the transaction.
×

2 Article(s) Remaining

Subscribe today for full access